Dialysis care provider VitusCare has raised $3 million in a Series B funding round with participation from Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors 1Crowd and 3i Partners, along with several angel investors.
The Gurugram-based company had previously raised $2.7 million in a Series A round led by Tomorrow Capital in April 2024 and Rs 10.83 crore in a seed round in 2019.
The fresh capital will be deployed towards expanding its dialysis centre network, technology development, workforce training and international expansion, VitusCare said in a press release.
The fundraise comes as VitusCare has nearly tripled its revenue since its previous funding round in 2024. The company has expanded its network from 22 to more than 60 dialysis centres across nine states and over 50 cities.
So far, VitusCare has treated more than 35,000 patients and conducted over 8 lakh dialysis sessions. Its workforce has also grown from 110 to 300 employees.
The company said it reported positive corporate EBITDA in FY26, supported by faster breakeven at newly opened centres and same-centre growth of over 30%.
Founded in 2017 by Prabhat Shrivastava, VitusCare operates through a capital-light ‘shop-in-shop’ model. It partners with existing hospitals to provide specialised dialysis services instead of setting up standalone facilities.
The company aims to expand its network to more than 100 centres by the end of FY27. It is also exploring opportunities in select Asian markets.
VitusCare is also developing AI-native business modules to improve healthcare delivery and plans to establish a Technician Academy to train dialysis professionals.
Source link




![Funding and acquisitions in Indian startups this week [Nov 16- Nov 21]](https://images.themorningpulse.fyi/uploads/2026/11/rss-mwqdyjue-v60xob-media.png)


